Enhancing Facial Nerve Function With Omega-3 After Resection of Vestibular Schwannoma
Condition(s):Vestibular SchwannomaLast Updated:September 8, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Vestibular SchwannomaLast Updated:September 8, 2023Terminated
Condition(s):Vestibular Schwannoma; Neurinoma, Acoustic; Acoustic NeuromaLast Updated:November 1, 2023Not yet recruiting
Condition(s):Vestibular SchwannomaLast Updated:October 5, 2022Not yet recruiting
Condition(s):Vestibular SchwannomaLast Updated:October 20, 2022Completed
Condition(s):Vestibular SchwannomaLast Updated:December 11, 2023Not yet recruiting
Condition(s):Vestibular SchwannomaLast Updated:April 4, 2023Recruiting
Condition(s):Vestibular Schwannoma; OtotoxicityLast Updated:July 7, 2023Recruiting
Condition(s):Vestibular Schwannoma; Vestibular Function DisorderLast Updated:August 20, 2018Completed
Condition(s):Vestibular SchwannomaLast Updated:February 8, 2024Recruiting
Condition(s):Vestibular Schwannoma; Acoustic Neuroma; Sensorineural Hearing Loss; Asymmetric Sensorineural Hearing Loss; Cochlear Nerve Damage; Cochlear Nerve Deafness; Skull Base Neoplasms; Auditory; NerveLast Updated:December 12, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.